Virobay Inc. Report issue

For profit Phase 1
Founded: Menlo Park CA United States (2006)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2007
NCT00557583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (3)

vby-036 (2 trials)

vby-376 (1 trial)

vby-891 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 1)

Hepatitis C (Phase 1)

Hepatitis C, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3